Session Chair Profile

Ph.D., M.D., M.A.S., Lee Goldman, MD, Endowed Chair in Medicine; Professor of Medicine and of Epidemiology and Biostatistics, University of California, San Francisco (UCSF)
Biography

Dr. Bibbins-Domingo has expertise in cardiovascular epidemiology, particularly hypertension and chronic heart failure; racial, ethnic, and income disparities in health; and clinical and public health interventions aimed at chronic disease prevention. She is the director of the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, and is also the director of the UCSF Clinical and Translational Science Institute’s training programs, which provide clinical and translational research education and training for researchers at all levels. Dr. Bibbins-Domingo earned her A.B. in molecular biology from Princeton University, where she pursued a joint degree in the Woodrow Wilson School of Public and International Affairs. Dr. Bibbins-Domingo spent 2 years at the University of Ibadan in Nigeria, where she earned an M.S. in chemistry. She earned her Ph.D. in biochemistry, her M.D., and her M.A.S. in clinical research at UCSF, where she completed her residency and fellowship training. She was also a Robert Wood Johnson Amos Scholar and a Kellogg Scholar in health disparities.

Session Abstract – PMWC 2017 Silicon Valley

Session Synopsis: This session explores the essential role of population level data in achieving precision medicine. The panelists will discuss opportunities for integration and application of data from across the spectrum of health (e.g. social, environmental, molecular factors) to inform prediction of individual risk, guide tailored prevention strategies, and improve early screening and diagnostics.

Get Exclusive Access to the Top PMWC Talks

To receive the most comprehensive news and updates from the field of precision medicine, subscribe to the newsletter here.

Bonus for suscribing, you will get the access code for the top 3 talk videos from January's Precision Medicine World Conference.

You have successfully subscribed, you can access the talks here.